ALMLB Fundamental Analysis - MILIBOO SA

Name: MILIBOO SA (ALMLB) Stock
Brand: MILIBOO SA
Rating: 1 (3 reviews)

Fundamental Rating

ALMLB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 34 industry peers in the Household Durables industry. While ALMLB seems to be doing ok healthwise, there are quite some concerns on its profitability. ALMLB has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALMLB had negative earnings in the past year.

ALMLB had a negative operating cash flow in the past year.

In multiple years ALMLB reported negative net income over the last 5 years.

In multiple years ALMLB reported negative operating cash flow during the last 5 years.

1.2 Ratios

ALMLB has a worse Return On Assets (-1.61%) than 76.47% of its industry peers.

ALMLB has a worse Return On Equity (-3.94%) than 76.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.61%
ROE	-3.94%
ROIC	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALMLB's Gross Margin of 26.58% is on the low side compared to the rest of the industry. ALMLB is outperformed by 64.71% of its industry peers.

In the last couple of years the Gross Margin of ALMLB has remained more or less at the same level.

ALMLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	26.58%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALMLB has about the same amout of shares outstanding than it did 1 year ago.

ALMLB has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ALMLB has an improved debt to assets ratio.

2.2 Solvency

ALMLB has an Altman-Z score of 3.39. This indicates that ALMLB is financially healthy and has little risk of bankruptcy at the moment.

With a decent Altman-Z score value of 3.39, ALMLB is doing good in the industry, outperforming 79.41% of the companies in the same industry.

ALMLB has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.

ALMLB has a better Debt to Equity ratio (0.15) than 79.41% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	3.39

ROIC/WACCN/A

WACC7.07%

2.3 Liquidity

A Current Ratio of 1.78 indicates that ALMLB should not have too much problems paying its short term obligations.

The Current ratio of ALMLB (1.78) is better than 64.71% of its industry peers.

A Quick Ratio of 0.85 indicates that ALMLB may have some problems paying its short term obligations.

ALMLB has a Quick ratio (0.85) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALMLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.80%.

ALMLB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.02%.

Measured over the past years, ALMLB shows a small growth in Revenue. The Revenue has been growing by 5.42% on average per year.

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.16%

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

3.2 Future

ALMLB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.83% yearly.

The Revenue is expected to decrease by -8.53% on average over the next years.

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

EPS Next 5YN/A

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-8.53%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALMLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

ALMLB is valuated cheaply with a Price/Forward Earnings ratio of 4.78.

94.12% of the companies in the same industry are more expensive than ALMLB, based on the Price/Forward Earnings ratio.

The average S&P500 Price/Forward Earnings ratio is at 34.59. ALMLB is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.78

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALMLB indicates a slightly more expensive valuation: ALMLB is more expensive than 70.59% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2639.7

4.3 Compensation for Growth

ALMLB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

ALMLB's earnings are expected to decrease with -31.83% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALMLB does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MILIBOO SA

EPA:ALMLB (11/14/2025, 7:00:00 PM)

1.49

-0.07 (-4.49%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners43%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap10.33M

Revenue(TTM)38.98M

Net Income(TTM)-257.00K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.78
P/S	0.26
P/FCF	N/A
P/OCF	N/A
P/B	1.58
P/tB	2.4
EV/EBITDA	2639.7

EPS(TTM)-0.04

EYN/A

EPS(NY)0.31

Fwd EY20.92%

FCF(TTM)-0.18

FCFYN/A

OCF(TTM)-0.06

OCFYN/A

SpS5.62

BVpS0.94

TBVpS0.62

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.61%
ROE	-3.94%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	26.58%
FCFM	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

F-Score2

Asset Turnover2.45

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	236.75
Cap/Depr	162.09%
Cap/Sales	2.15%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.78
Quick Ratio	0.85
Altman-Z	3.39

F-Score2

WACC7.07%

ROIC/WACCN/A

Cap/Depr(3y)200.54%

Cap/Depr(5y)208.68%

Cap/Sales(3y)2.1%

Cap/Sales(5y)2.06%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.16%

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

EPS Next 5YN/A

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-8.53%

Revenue Next 5YN/A

EBIT growth 1Y-118.29%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.04%

EBIT Next 3Y-21.18%

EBIT Next 5YN/A

FCF growth 1Y-215.16%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-118.08%

OCF growth 3YN/A

OCF growth 5YN/A

MILIBOO SA / ALMLB.PA FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMLB.PA.

What is the valuation status for ALMLB stock?

ChartMill assigns a valuation rating of 4 / 10 to MILIBOO SA (ALMLB.PA). This can be considered as Fairly Valued.

How profitable is MILIBOO SA (ALMLB.PA) stock?

MILIBOO SA (ALMLB.PA) has a profitability rating of 1 / 10.

Can you provide the financial health for ALMLB stock?

The financial health rating of MILIBOO SA (ALMLB.PA) is 4 / 10.

MILIBOO SA (ALMLB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MILIBOO SA / ALMLB.PA FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

What is the valuation status for ALMLB stock?

How profitable is MILIBOO SA (ALMLB.PA) stock?

Can you provide the financial health for ALMLB stock?